July 14, 2024: Ozempic Lawsuit Intensifies with New Studies Linking Drug to Vision Loss The Ozempic blindness and vision loss lawsuit is full steam ahead following the July 2024 study indicating huge increases in the risk of NAION for users of semaglutide
Phentermine is a prescription appetite suppressant that has been safely used for decades as a short-term kickstart for weight loss
NR4A1 is capable of directly interacting with metformin, influencing the localization of Liver Kinase B1 (LKB1), activating AMPK, and decreasing the generation of inflammatory signals and intracellular ROS
B, Biointerfaces, 117, 330337
Free radicals are the byproducts of oxidative metabolism in mitochondria
Combining MBOAT1/2-enhancing interventions with antioxidants or ferroptosis inhibitors may yield synergistic effects